[Zeta Corporation] CEA‐M (CEA31) Mouse Monoclonal Antibody

[Zeta Corporation] CEA‐M (CEA31) Mouse Monoclonal Antibody

Z2100ML 1.0 ml (Concentrate)
Z2100MS 0.5 ml (Concentrate)
Z2100MT 0.1 ml (Concentrate)
Z2100MP 7 mL (pre‐dilute)

 

Intended Use
This antibody is intended for in vitro diagnostic (IVD) use.
CEA‐M (CEA31) Mouse Monoclonal Primary Antibody is
intended for laboratory professional use in the detection of
the CEA protein in formalin‐fixed, paraffin‐embedded tissue
stained in manual qualitative immunohistochemistry (IHC)
testing.

This antibody is intended to be used after the primary
diagnosis of tumor has been made by conventional
histopathology using non‐immunological histochemical
stains. The results using this product must be interpreted by
a qualified pathologist as an aid to diagnosis in conjunction
with the patient’s relevant clinical history, other diagnostic
tests and proper controls.

Summary and Explanation
Clone CEA31 has a high affinity for CEA and shows no
detectable reactivity to nonspecific cross‐reacting antigen
(NCA), biliary glycoprotein (BGP).and human
polymorphonuclear leucocytes. Ab‐3 shows no reaction with
a variety of normal tissues. CEA is not found in benign glands,
stroma, or malignant prostatic cells. Antibody to CEA is useful
in detecting early foci of gastric carcinoma and in
distinguishing pulmonary adenocarcinomas (60‐70% are
CEA+) from pleural mesotheliomas (rarely or weakly CEA+).